InxMed Co., Ltd. announced that IN10018, its focal adhesion kinase (FAK) inhibitor, had been granted with Breakthrough Therapy Designation by the China National Medical...
Juniper Biologics, a science-led healthcare company focused on researching, developing and commercializing novel therapies announced that it has gained the licensing rights to develop...
The Oklahoma Proton Center celebrated the graduation of its 4,000th patient. Mr. Eric Green was a 59-year-old prostate cancer patient who chose the Oklahoma...
HanAll Biopharma and Daewoong Pharmaceutical announced expansion of their open collaboration strategy by investing in Turn Biotechnologies, a Silicon Valley based company focused on...
Rockwell Medical, Inc., a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, announced an expanded partnership with DaVita Inc.,...
